BRIEF published on 01/23/2026 at 19:05, 2 months ago ABIONYX Pharma dévoile son calendrier financier 2026 ABIONYX Pharma Sepsis Thérapies Innovantes Calendrier Financier 2026 Soins Critiques
BRIEF published on 01/23/2026 at 19:05, 2 months ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
BRIEF published on 01/23/2026 at 19:05, 2 months ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
PRESS RELEASE published on 01/23/2026 at 19:00, 2 months ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
PRESS RELEASE published on 01/23/2026 at 19:00, 2 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce son calendrier de communication financière pour l’exercice 2026, incluant les résultats annuels et semestriels ainsi que les positions de trésorerie Communication Financière Biopharmaceutique ABIONYX Pharma Sepsis Calendrier 2026
BRIEF published on 01/07/2026 at 19:17, 2 months 16 days ago Bilan semestriel du contrat de liquidité d'ABIONYX Pharma Contrat De Liquidité TP ICAP Europe Transactions Boursières ABIONYX Pharma Actions Et Espèces
BRIEF published on 01/07/2026 at 19:17, 2 months 16 days ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
PRESS RELEASE published on 01/07/2026 at 19:12, 2 months 16 days ago Informations privilégiées / Autres communiqués Bilan semestriel du contrat de liquidité d'ABIONYX Pharma avec TP ICAP (Europe) SA : achat de 437 203 titres pour 1 389 323,53€ et vente de 536 477 titres pour 1 560 333,66€ Contrat De Liquidité TP ICAP Achat Vente ABIONYX Pharma
PRESS RELEASE published on 01/07/2026 at 19:12, 2 months 16 days ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
BRIEF published on 12/16/2025 at 21:23, 3 months 7 days ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
Published on 03/24/2026 at 08:01, 2 hours 3 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 3 hours 4 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 3 hours 4 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/23/2026 at 22:40, 11 hours 24 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/24/2026 at 09:21, 42 minutes ago More than 3,000 GHG credits successfully processed: Customers benefit from the services of the Allane Mobility Group
Published on 03/24/2026 at 09:15, 48 minutes ago Julius Baer Group Ltd. to redeem Perpetual Tier 1 Subordinated Bonds issued 8 October 2020 on first call date
Published on 03/24/2026 at 09:10, 54 minutes ago DN Group AG acquires a stake in WINDWISE / Further expansion of the portfolio
Published on 03/24/2026 at 09:05, 58 minutes ago Nagarro announces preliminary numbers for FY 2025, guidance for FY 2026, and conclusion of independent investigation
Published on 03/24/2026 at 09:05, 58 minutes ago MSI Highlights Cloud, AI, and Enterprise Server Platforms at CloudFest 2026
Published on 03/24/2026 at 07:45, 2 hours 19 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 2 hours 19 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 2 hours 34 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 2 hours 34 minutes ago Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 14 hours 55 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
